Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014435 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014436 |
| CAS No | NA |
| Mol.F. | C24H25Cl2N5O4 |
| Mol.Wt. | 518.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014437 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 282.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014438 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.56 |
| INV STATUS | In Stock |
| CAT No | SRC-N014439 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014440 |
| CAS No | NA |
| Mol.F. | C21H19N3O3 |
| Mol.Wt. | 361.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014441 |
| CAS No | NA |
| Mol.F. | C35H29N3O5 |
| Mol.Wt. | 571.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014442 |
| CAS No | 77400-46-5 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.17 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014443 |
| CAS No | NA |
| Mol.F. | C16H22N2O5 |
| Mol.Wt. | 322.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014444 |
| CAS No | NA |
| Mol.F. | C31H41N3O8 |
| Mol.Wt. | 583.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014445 |
| CAS No | NA |
| Mol.F. | C18H20N4O2 |
| Mol.Wt. | 324.38 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014446 |
| CAS No | NA |
| Mol.F. | C28H30N4O7 |
| Mol.Wt. | 534.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014447 |
| CAS No | NA |
| Mol.F. | C10H14N4O6 |
| Mol.Wt. | 286.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014448 |
| CAS No | NA |
| Mol.F. | C17H14BrF2N5O4 |
| Mol.Wt. | 470.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014449 |
| CAS No | NA |
| Mol.F. | C12H14N4O3S |
| Mol.Wt. | 294.33 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014450 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |